Research ArticleArticle
Baseline Numbers of Circulating CD28-negative T Cells May Predict Clinical Response to Abatacept in Patients with Rheumatoid Arthritis
MIRKO SCARSI, TAMARA ZIGLIOLI and PAOLO AIRO’
The Journal of Rheumatology October 2011, 38 (10) 2105-2111; DOI: https://doi.org/10.3899/jrheum.110386
MIRKO SCARSI
TAMARA ZIGLIOLI
PAOLO AIRO’
REFERENCES
- 1.↵
- Isaacs JD,
- Ferraccioli G
- 2.↵
- 3.↵
- 4.↵
- Scarsi M,
- Ziglioli T,
- Airo’ P
- 5.↵
- 6.↵
- Gerli R,
- Schillaci G,
- Giordano A,
- Bocci EB,
- Bistoni O,
- Vaudo G,
- et al.
- 7.↵
- Lake RA,
- O’Hehir RE,
- Verhoef A,
- Lamb JR
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Wells G,
- Becker JC,
- Teng J,
- Dougados M,
- Schiff M,
- Smolen J,
- et al.
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- Buch MH,
- Boyle DL,
- Rosengren S,
- Saleem B,
- Reece RJ,
- Rhodes LA,
- et al.
- 16.↵
- 17.↵
- 18.↵
- 19.↵
In this issue
The Journal of Rheumatology
Vol. 38, Issue 10
1 Oct 2011
Baseline Numbers of Circulating CD28-negative T Cells May Predict Clinical Response to Abatacept in Patients with Rheumatoid Arthritis
MIRKO SCARSI, TAMARA ZIGLIOLI, PAOLO AIRO’
The Journal of Rheumatology Oct 2011, 38 (10) 2105-2111; DOI: 10.3899/jrheum.110386